Restricted accessResearch articleFirst published online 2020-5
Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis
We aimed to explore the prognostic value of primary tumor and specific metastases excision on survival among patients with stage IV colorectal cancer (CRC) in the Surveillance, Epidemiology, and End Results (SEER) database.
Methods
Patients with stage IV CRC were selected using SEER database between 2010 and 2013. Survival rate was calculated according to the Kaplan-Meier method, and differences between curves were tested by the log-rank test. Cox proportional hazards model was used in the multivariable analysis.
Results
Included in this study were 27 878 patients with distant metastatic CRC. Among the single organ site of metastatic CRC, patients with solitary metastasis of lung showed the highest median overall survival (OS). Both primary and metastatic sites surgical resection for patients with liver, lung, and simultaneous liver and lung metastases had better median OS. Age younger than 65 years, Asian and Pacific Islander, distal colon and rectum, and palliative primary tumor and metastatic lesions resection were associated with better OS after multivariate analysis. Palliative primary tumor and metastatic lesions resection had a significant survival benefit compared with nonsurgical group in selected patients.
Conclusion
These findings support the use of preemptive surgery in the management of highly selected metastatic CRC patients.
SiegelRL.MillerKD.FedewaSAet al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177-193.doi:10.3322/caac.21395http://www.ncbi.nlm.nih.gov/pubmed/28248415
2.
LinB-R.ChangT-C.LeeY-C.LeeP-H.ChangK-J.LiangJ-T. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor. Ann Surg Oncol. 2009;16(4):1026-1032.doi:10.1245/s10434-008-0286-3http://www.ncbi.nlm.nih.gov/pubmed/19184237
3.
NeeffH.HörthW.MakowiecFet al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13(10):1813-1820.doi:10.1007/s11605-009-0960-1http://www.ncbi.nlm.nih.gov/pubmed/19593668
4.
Van CutsemE.CervantesA.AdamRet al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422.doi:10.1093/annonc/mdw235http://www.ncbi.nlm.nih.gov/pubmed/27380959
5.
KataokaK.KanazawaA.NakajimaA.YamaguchiA.ArimotoA.KohnoY. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study. Surg Today. 2013;43(10):1154-1161.doi:10.1007/s00595-012-0410-7http://www.ncbi.nlm.nih.gov/pubmed/23139049
6.
LongoWE.VirgoKS.JohnsonFEet al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum. 2000;43(1):83-91.doi:10.1007/BF02237249http://www.ncbi.nlm.nih.gov/pubmed/10813129
7.
LegendreH.VanhuyseF.Caroli-BoscFX.PectorJC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol. 2001;27(4):364-367.doi:10.1053/ejso.2001.1120http://www.ncbi.nlm.nih.gov/pubmed/11417981
8.
KimMS.ChungM.AhnJBet al. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. J Surg Oncol. 2014;110(2):214-221.doi:10.1002/jso.23607http://www.ncbi.nlm.nih.gov/pubmed/24668581
9.
TebbuttNC.NormanAR.CunninghamDet al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003;52(4):568-573.doi:10.1136/gut.52.4.568http://www.ncbi.nlm.nih.gov/pubmed/12631671
10.
SeoGJ.ParkJW.YooSBet al. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol. 2010;102(1):94-99.doi:10.1002/jso.21577http://www.ncbi.nlm.nih.gov/pubmed/20578086
11.
CirocchiR.TrastulliS.AbrahaIet al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;8(8):CD008997.doi:10.1002/14651858.CD008997.pub2http://www.ncbi.nlm.nih.gov/pubmed/22895981
12.
KanasGP.TaylorA.PrimroseJNet al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301.doi:10.2147/CLEP.S34285http://www.ncbi.nlm.nih.gov/pubmed/23152705
13.
OweiraH.PetrauschU.HelblingDet al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysis. World J Gastroenterol. 2017;23(10):1872-1880.doi:10.3748/wjg.v23.i10.1872http://www.ncbi.nlm.nih.gov/pubmed/28348494
14.
SimmondsPC.PrimroseJN.ColquittJL.GardenOJ.PostonGJ.ReesM. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982-999.doi:10.1038/sj.bjc.6603033http://www.ncbi.nlm.nih.gov/pubmed/16538219
15.
SchmidtC. Metastatic colorectal cancer: is surgery necessary?J Natl Cancer Inst. 2009;101(16):1113-1115.doi:10.1093/jnci/djp269http://www.ncbi.nlm.nih.gov/pubmed/19671774
16.
WancataLM.BanerjeeM.MuenzDG.HaymartMR.WongSL. Conditional survival in advanced colorectal cancer and surgery. J Surg Res. 2016;201(1):196-201.doi:10.1016/j.jss.2015.10.021http://www.ncbi.nlm.nih.gov/pubmed/26850202
17.
VargasGM.SheffieldKM.ParmarADet al. Trends in treatment and survival in older patients presenting with stage IV colorectal cancer. J Gastrointest Surg. 2014;18(2):369-377.doi:10.1007/s11605-013-2406-zhttp://www.ncbi.nlm.nih.gov/pubmed/24234244
18.
AbdelsattarZM.WongSL.RegenbogenSE.JomaaDM.HardimanKM.HendrenS. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929-934.doi:10.1002/cncr.29716http://www.ncbi.nlm.nih.gov/pubmed/26808454
19.
HorowitzNS.MillerA.RungruangBet al. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015;33(8):937-943.doi:10.1200/JCO.2014.56.3106http://www.ncbi.nlm.nih.gov/pubmed/25667285
20.
CollinsA.HatzarasI.SchmidtCet al. Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improve survival in select patients. J Gastrointest Surg. 2014;18(3):491-496.doi:10.1007/s11605-013-2415-yhttp://www.ncbi.nlm.nih.gov/pubmed/24234246
21.
CulpSH.SchellhammerPF.WilliamsMB. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol. 2014;65(6):1058-1066.doi:10.1016/j.eururo.2013.11.012http://www.ncbi.nlm.nih.gov/pubmed/24290503
22.
AbubakerK.LatifiA.LuworRet al. Short-Term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer. 2013;12:24.doi:10.1186/1476-4598-12-24http://www.ncbi.nlm.nih.gov/pubmed/23537295
23.
TarantinoI.WarschkowR.WorniMet al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity Score-Adjusted trend analysis. Ann Surg. 2015;262(1):112-120.doi:10.1097/SLA.0000000000000860http://www.ncbi.nlm.nih.gov/pubmed/25373464
24.
XuH.XiaZ.JiaXet al. Primary tumor resection is associated with improved survival in stage IV colorectal cancer: an instrumental variable analysis. Sci Rep. 2015;5:16516.doi:10.1038/srep16516http://www.ncbi.nlm.nih.gov/pubmed/26563729
25.
MurphyCC.HarlanLC.LundJL.LynchCF.GeigerAM. Patterns of colorectal cancer care in the United States: 1990-2010. J Natl Cancer Inst. 2015;107(10). 23 07 2015.doi:10.1093/jnci/djv198http://www.ncbi.nlm.nih.gov/pubmed/26206950
26.
PageAJ.EjazA.SpolveratoGet al. Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation. J Gastrointest Surg. 2015;19(2):387-399.doi:10.1007/s11605-014-2712-0http://www.ncbi.nlm.nih.gov/pubmed/25472030
27.
BuchsNC.RisF.MajnoPEet al. Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer. Ann Surg Oncol. 2015;22(3):931-937.doi:10.1245/s10434-014-4069-8http://www.ncbi.nlm.nih.gov/pubmed/25201505
28.
ViganòL.CapussottiL.LapointeRet al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276-1286.doi:10.1245/s10434-013-3421-8http://www.ncbi.nlm.nih.gov/pubmed/24346766
29.
SabolchA.ElseT.GriffithKAet al. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. Int J Radiat Oncol Biol Phys. 2015;92(2):252-259.doi:10.1016/j.ijrobp.2015.01.007http://www.ncbi.nlm.nih.gov/pubmed/25754631
30.
AhmedS.JohnsonK.AhmedO.IqbalN. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis. 2014;29(9):1031-1042.doi:10.1007/s00384-014-1928-5http://www.ncbi.nlm.nih.gov/pubmed/24953060
31.
KopetzS.ChangGJ.OvermanMJet al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677-3683.doi:10.1200/JCO.2008.20.5278http://www.ncbi.nlm.nih.gov/pubmed/19470929
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
